Table 3.
Questionnaire scores (ACQ-6, miniAQLQ, HADS) and control markers.
| Asthma symptom scores and control | N = 308a |
|---|---|
| Annual SABA use | 120 (0, 240) |
| ≥600 doses | 175 (57%) |
| History of moderate exacerbation(s) | 37 (12%) |
| Annual exacerbation rate | 1.00 (1.00, 2.00) |
| History of severe exacerbation(s) | 12 (3.8%) |
| Annual exacerbation rate | 1.00 (1.00, 1.00) |
| ACQ-6 (n = 252) | 1.14 (0.43, 2.00) |
| ≥1.5 | 94 (37%) |
| miniAQLQ | |
| Total Score | 4.93 (3.85, 5.47) |
| <5.4 | 227 (72%) |
| Symptom score | 4.80 (3.60, 5.40) |
| Activity score | 5.25 (4.25, 5.75) |
| Emotional score | 4.67 (3.67, 5.67) |
| Environment score | 5.00 (3.42, 5.67) |
| HADS | |
| Anxiety score | 5.0 (2.0, 8.0) |
| ≥8 | 86 (27%) |
| Depression score | 2.0 (1.0, 5.0) |
| ≥8 | 44 (14%) |
aMedian (IQR); n (%).
ACQ, Asthma Control Questionnaire; HADS, Hospital Anxiety and Depression Scale; Mini AQLQ, Mini Asthma Quality of Life Questionnaire; SABA, short acting beta-2-agonist.